Repeat or Single Quadratus Lumborum Block for the Reduction of Opioid Prescriptions After Surgery in Retroperitoneal Sarcoma Patients ( " RESQU-SARC " Trial)

Condition:   Retroperitoneal Sarcoma Interventions:   Drug: Liposomal Bupivacaine;   Drug: Quadratus Lumborum Block;   Other: Questionnaire Administration Sponsors:   M.D. Anderson Cancer Center;   National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials

Related Links:

Publication date: January 2020Source: Journal of Comparative Pathology, Volume 174Author(s): F. Romero-Palomo, D. Devaux, K. Nuss, A. Kipar
Source: Journal of Comparative Pathology - Category: Pathology Source Type: research
Publication date: January 2020Source: Journal of Comparative Pathology, Volume 174Author(s): G. Avallone, M. De Marino, M.E. Turba, B. Brunetti, P. Roccabianca
Source: Journal of Comparative Pathology - Category: Pathology Source Type: research
Although there have been multiple randomised trials in newly diagnosed Ewing sarcoma family of tumours (ESFT) and these have been conducted over many years and involved many international cooperative groups, t...
Source: Trials - Category: General Medicine Authors: Tags: Study protocol Source Type: research
Publication date: Available online 15 January 2020Source: Journal of Minimally Invasive GynecologyAuthor(s): Simona Zaami, Errico Zupi, Lucia Lazzeri, Michael Stark, Antonio Malvasi, Fabrizio Signore, Enrico MarinelliABSTRACTPower morcellation in the context of laparoscopic surgery enables specialists to carry out minimally invasive procedures such as hysterectomies and myomectomies by cutting specimens into smaller pieces using a rotating blade and removing pieces through a laparoscope. Unexpected uterine sarcoma treated by surgery involving tumor disruption could be associated with poor prognosis. The current study aims ...
Source: Journal of Minimally Invasive Gynecology - Category: OBGYN Source Type: research
Authors: Matsumoto M, Kasai T, Saito A, Takanobu K, Senoh H, Umeda Y, Kanno J Abstract Butyl 2,3-epoxypropyl ether (CAS No. 2426-08-6, synonym: n-butylglycidyl ether, BGE) was exposed by whole body inhalation to F344 rats and BDF1 mice of both sexes (50 animals per group) 6 hours per day, 5 days per week for 104 weeks at targeted concentrations of 0, 10, 30 or 90 ppm (v/v) for rats and 0, 5, 15 or 45 ppm for mice. In rats, 90 ppm of BGE increased the incidences of nasal squamous cell carcinomas in both sexes. Nasal adenomas and splenic mononuclear cell leukemia were increased in male rats exposed to 30 ppm. Splenic...
Source: Journal of Toxicological Sciences - Category: Toxicology Tags: J Toxicol Sci Source Type: research
Limb salvage for bone sarcoma around the knee in skeletally immature children is challenging because of interference on two critical growth plates in the lower limb. This retrospective study aims to evaluate l...
Source: Journal of Orthopaedic Surgery and Research - Category: Orthopaedics Authors: Tags: Research article Source Type: research
AbstractBackgroundTo report on our experience using a simple optional form to facilitate communication on late effects between the patients and the oncologists during outpatient follow-up and to detail on the spectrum of challenges reported by sarcoma survivors.MethodsThe form was presented for the patients to complete before their consultation and covered topics related to late effects and unmet needs that the patient wished to discuss with the medical personnel. Logistic regression analysis examined how the distribution of the topics varied with age, gender, diagnosis and type of treatment received.ResultsThe form was ma...
Source: Clinical Sarcoma Research - Category: Cancer & Oncology Source Type: research
ConclusionsThe clinical manifestations of RPTs were extremely variable. Recurrence after repeating resection is commonly observed in patients with malignant retroperitoneal sarcoma.
Source: International Journal of Clinical Oncology - Category: Cancer & Oncology Source Type: research
ashi Soft tissue sarcoma (STS) is a rare component of malignant diseases. STS includes various histological subtypes, and there are some important differences among the different histological subtypes regarding the mutation profile and sensitivity to antitumor agents. Many clinical trials of STS incorporating many different histological subtypes in various populations have been conducted; it is difficult to compare the findings and make conclusions about clinical efficacy. Targeted therapies focusing on specific histological subtypes and precision therapy focusing on the specific genetic mutation(s) of each STS patient...
Source: Cancers - Category: Cancer & Oncology Authors: Tags: Review Source Type: research
e; DR PMID: 31949013 [PubMed - as supplied by publisher]
Source: Haematologica - Category: Hematology Authors: Tags: Haematologica Source Type: research
More News: Cancer & Oncology | Research | Sarcomas